Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Assets Average: 2021-2025

Historic Assets Average for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $873.1 million.

  • Maravai Lifesciences Holdings' Assets Average fell 35.85% to $873.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $873.1 million, marking a year-over-year decrease of 35.85%. This contributed to the annual value of $1.2 billion for FY2024, which is 33.80% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Assets Average stood at $873.1 million, which was down 5.95% from $928.4 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Assets Average peaked at $2.3 billion during Q1 2023, and registered a low of $873.1 million during Q3 2025.
  • Its 3-year average for Assets Average is $1.5 billion, with a median of $1.4 billion in 2024.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Assets Average soared by 51.06% in 2022, and later tumbled by 39.94% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Assets Average (Quarterly) stood at $1.9 billion in 2021, then grew by 18.84% to $2.3 billion in 2022, then dropped by 17.13% to $1.9 billion in 2023, then tumbled by 39.11% to $1.1 billion in 2024, then crashed by 35.85% to $873.1 million in 2025.
  • Its last three reported values are $873.1 million in Q3 2025, $928.4 million for Q2 2025, and $984.0 million during Q1 2025.